| | | What you talkin about "huge shares outstanding" ??? 1/2 as many out as BZI and less than HTL . Difference is CZO has just built a new factory and earned 4 mil last year. I see no problem with CZO share count. If you do move on. I am not here to pump CZO it does a fine job all on its own. Earned almost 2 mil last quarter which puts them well over what HTL BZI and AKR earned in past twelve months .
Did you notice the +800K of deferred revenue on the 4th quarter. Seems customers can't get enough of CZO patented product. That is prepaid sales orders which would have taken Q4 earnings well over $2mil dollars closer to $2.5 mil. Thats about .15 cents per share earnings for that huge 65 mil fd shares. :))
Symrise pretty nice customer to have though isn't it...???
10. DEFERRED REVENUE During the year ended December 31, 2015, the Company received $300,000 (2014 - $89,100) from Alberta Innovates Bio Solutions (AI-Bio Solutions) under non-repayable grant agreements to fund research projects. During the year ended December 31, 2015, the Company has expended $66,983 (2014 - $22,117). The balance of the grants received of $300,000 at December 31, 2015 (2014 - $66,983) are restricted for eligible project expenditures which have not yet been incurred so they have been presented as deferred revenue. Deferred revenue also consists of $872,198 (2014 - $95,296) for prepaid sales orders from customers.
stockwatch.com |
|
